Glenn Jeffrey S 4
4 · Eiger BioPharmaceuticals, Inc. · Filed Mar 11, 2022
Insider Transaction Report
Form 4
Glenn Jeffrey S
Director
Transactions
- Award
Common Stock
2022-03-11+6,000→ 82,355 total - Award
Stock Option (Right to Buy)
2022-03-11+12,000→ 12,000 totalExercise: $5.10Exp: 2032-03-10→ Common Stock (12,000 underlying)
Holdings
- 5,000(indirect: By Spouse)
Common Stock
- 460(indirect: By son)
Common Stock
- 151,064(indirect: By Eiger Group International, Inc.)
Common Stock
Footnotes (3)
- [F1]Represents shares underlying Restricted Stock Units award that will vest on the first anniversary of the grant date of March 11, 2022.
- [F2]Shares are held by Eiger Group International, Inc. ("EGI"). The Reporting Person is the Chief Executive Officer of EGI and has sole power to vote and sole power to dispose of shares directly owned by EGI. The Reporting Person disclaims beneficial ownership of such shares except to the extent of any pecuniary interest therein.
- [F3]The option vests in equal monthly installments over 12 months measured from March 11, 2022 subject to Reporting Person's continuous service status as of each such date.